Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

98.29
BATS BZX Real-Time Price
As of 12:46pm ET
 -0.66 / -0.67%
Today’s Change
97.00
Today|||52-Week Range
153.15
-1.97%
Year-to-Date

Today’s Trading

Previous close98.95
Today’s open99.36
Day’s range97.00 - 99.67
Volume55,018
Average volume (3 months)1,600,721
Market cap$20.9B
Dividend yield--
Data as of 12:46pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+1,700.00%
Earnings growth (this year)-329.18%
Earnings growth (next 5 years)+75.95%
Revenue growth (last year)+46.70%
P/E ratioNM
Price/Sales17.60
Price/Book44.55

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+1.10+1.55%
ALXNAlexion Pharmaceutic...+0.02+0.02%
BAXBaxter International...+0.29+0.45%
MYLMylan NV+0.69+1.89%
Data as of 12:47pm ET, 11/21/2017

Financials

Next reporting dateFebruary 14, 2018
EPS forecast (this quarter)-$0.45
Annual revenue (last year)$1.1B
Annual profit (last year)$104.2M
Net profit margin9.43%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts